Gender Equity Along the Health Technology Development Pipeline: A Women in HEOR Forum
Speaker(s)
Moderator: Olivia Wu, PhD, Health Economics and Health Technology Assessment (HEHTA) and NIHR Evidence Synthesis Group at the Complex Reviews Synthesis Unit, University of Glasgow, Glasgow, UK
Speakers: Julia F. Slejko, PhD, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, USA; Grammati Sarri, PhD, MSc, DiDS, Cytel, London, LON, UK; Ipek Ozer Stillman, MS, MBA, Takeda, Cambridge, MA, USA
DESCRIPTION: The vision of the Women in HEOR initiative is to support the contribution of women in our field by serving as a catalyst for leadership and a platform for mentorship, collaboration, and networking. This Women in HEOR Forum will bring into focus gender equity as it relates to the health technology development pipeline. Panelists will address several topics in early phases of development such as the role of funding support of women’s health research, pharmaceutical manufacturer investments in women’s health products/treatments, regulation policy to ensure gender-appropriate data collection and research to identify unmet medical needs among women. Panelists will also consider later phase topics such as research that examines women’s access to treatments, reporting guidelines to consider women in health research, and representation in clinical trials.
The agenda for the session will include: 1) an introduction to the Women in HEOR initiative and its objectives and activities 2) brief remarks by each panelist, and 3) a moderated discussion of the above topics throughout the healthcare technology development pipeline. The panelists will engage with the audience through live polling and open Q&A. Attendees will gain valuable perspectives on gender equity perceived challenges, potential solutions, and current initiatives to address the issue. This session is open to all conference attendees.
Code
242
Topic
Organizational Practices